Daniel B Yarosh
Overview
Explore the profile of Daniel B Yarosh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
459
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Pelle E, Jian J, Declercq L, Dong K, Yang Q, Pourzand C, et al.
Photodermatol Photoimmunol Photomed
. 2011 Sep;
27(5):231-5.
PMID: 21950626
Background/purpose: Human skin is constantly exposed to ultraviolet A (UVA), which can generate reactive oxygen species and cause iron release from ferritin, leading to oxidative damage in biomolecules. This is...
12.
Querfeld C, Rosen S, Guitart J, Rademaker A, Pezen D, Dolan M, et al.
Clin Cancer Res
. 2011 Jul;
17(17):5748-54.
PMID: 21747120
Purpose: Temozolomide (TMZ) is an oral derivative of dacarbazine that induces DNA damage by methylating nucleotide bases. Resistance has been associated with high levels of O⁶-methylguanine-DNA methyltransferase (MGMT). Malignant CD4(+)...
13.
Ando H, Niki Y, Yoshida M, Ito M, Akiyama K, Kim J, et al.
Cell Logist
. 2011 Jun;
1(1):12-20.
PMID: 21686100
The mechanism of melanosome transfer from melanocytes to keratinocytes has not been fully clarified. We now show a route of melanosome transfer using co-cultures of normal human melanocytes and keratinocytes....
14.
Niki Y, Yoshida M, Ando H, Wakamatsu K, Ito S, Harada N, et al.
J Dermatol Sci
. 2011 Jun;
63(2):115-21.
PMID: 21680155
Background: 1-(2,4-Dihydroxyphenyl)-3-(2,4-dimethoxy-3-methylpheny)propane (DP) was reported as a novel tyrosinase inhibitor by Nesterov et al. In previous study, we showed that DP is an antioxidant and accelerates the fading of UVB-induced...
15.
Sojka M, Cummins P, Declercq L, Fthenakis C, Ionita-Manzatu M, Lee W, et al.
Photochem Photobiol Sci
. 2011 Mar;
10(7):1146-51.
PMID: 21448497
We have developed a technology to incorporate micronized titanium dioxide (TiO(2)), together with antioxidants, in particles of a UV-visible transparent polymer gel. These particles are coated with silica to avoid...
16.
Markova N, Karaman-Jurukovska N, Dong K, Damaghi N, Smiles K, Yarosh D
Free Radic Biol Med
. 2009 May;
46(8):1168-76.
PMID: 19439218
The cellular defense system against harmful levels of reactive oxygen species consists of antioxidant enzymatic activities and small nonenzymatic molecules. L-ergothioneine has long been recognized as a potent and stable...
17.
Dong K, Damaghi N, Picart S, Markova N, Obayashi K, Okano Y, et al.
Exp Dermatol
. 2008 May;
17(12):1037-44.
PMID: 18459971
Destruction of collagen is a hallmark of photoaging. The major enzyme responsible for collagen 1 digestion, matrix metalloproteinase-1 (MMP-1), is induced by exposure to sunlight. To study the molecular trigger...
18.
Wulff B, Schick J, Thomas-Ahner J, Kusewitt D, Yarosh D, Oberyszyn T
Photochem Photobiol
. 2007 Dec;
84(2):317-21.
PMID: 18086242
Nonmelanoma skin cancer resulting from UVB exposure is a large and growing problem in the United States. Production of reactive oxygen species (ROS) during the UVB-induced inflammatory response results in...
19.
Dong K, Damaghi N, Kibitel J, Canning M, Smiles K, Yarosh D
J Cosmet Dermatol
. 2007 Sep;
6(3):183-8.
PMID: 17760697
Background: L-ergothioneine (EGT) is a stable antioxidant found in food plants as well as in animal tissue undergoing relatively high levels of oxidative stress. Idebenone is a stable analog of...
20.
Smiles K, Dong K, Canning M, Grimson R, Walfield A, Yarosh D
J Cosmet Dermatol
. 2007 May;
6(2):83-8.
PMID: 17524123
Background: Long-term treatment with a high-strength hydroquinone (HQ) cream (usually 4% HQ) is the mainstay therapy for hyperpigmentation disorders. Instability and high potential for irritancy hinders patient compliance. A new...